Insider · CIK 0001268854
Brent L Saunders
Files at SPRY (ARS Pharmaceuticals, Inc.), SKIN (Beauty Health Co), BLCO (Bausch & Lomb Corp). First filing May 22, 2025, latest May 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SPRY: ARS Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | BLCObuy Bausch & Lomb Corp | $248k 22,000 shares | +3% | - | |
| 60Notable | ARS Pharmaceuticals, Inc. | $1.7M 120,000 shares | -100% | +41% from low-18% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2025 | SPRY ARS Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 27, 2025 |
| Jun 16, 2025 | SKIN Beauty Health Co | AGrant or award Class A Common Stock | +73,051 | - | - | 5,994,820 | Jun 18, 2025 |
| May 22, 2025 | BLCO Bausch & Lomb Corp | POpen-market purchase Common Shares, No Par Value | +22,000 | $11.28 | $248k | 719,156 | May 27, 2025 |
| May 22, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +22,000 | $0.00 | $0 | 741,156 | May 27, 2025 |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Common Stock | +120,000 | $1.01 | $121k | 120,000 | May 22, 2025 |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -120,000 | $14.25 | $1.7M | 0 | May 22, 2025 |
| May 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -120,000 | $0.00 | $0 | 470,950 | May 22, 2025 |
| Feb 26, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Common Shares, No Par Value | +168,168 | $0.00 | $0 | 697,156 | Feb 28, 2025 |
| Feb 26, 2025 | BLCO Bausch & Lomb Corp | AGrant or award Non-Qualified Stock Options (right to purchase)derivative | +600,858 | $0.00 | $0 | 600,858 | Feb 28, 2025 |
| Dec 23, 2024 | BLCO Bausch & Lomb Corp | FTax withholding Common Shares, No Par Value | -73,782 | $17.83 | $1.3M | 553,637 | Dec 26, 2024 |
| Dec 23, 2024 | BLCO Bausch & Lomb Corp | FTax withholding Common Shares, No Par Value | -24,649 | $17.83 | $439k | 528,988 | Dec 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.